Combined radiation and chemotherapy in posttransplant lymphoproliferative disorder
The optimal treatment for posttransplant lymphoproliferative disorder which has progressed despite a reduction in immunosuppression has not been defined. We report on two patients with stage I posttransplant lymphoproliferative disorder who developed progressive disease despite a reduction in the level of immunosuppression. Both patients were treated with combined short course CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) chemotherapy followed by involved-field radiation therapy. In both patients, a rapid response was obtained followed by complete remission. Combined modality therapy can be utilized successfully in progressive limited stage posttransplant lymphoproliferative disorder.
Keywordsposttransplant lymphoproliferative disorder chemotherapy radiation therapy
Morrison VAet al.
Clinical characteristics of posttransplant lymphoproliferative disorders.Am J Med
: 14–24.PubMedCrossRefGoogle Scholar
Starzl TEet al.
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy.Lancet
: 583–587.CrossRefGoogle Scholar
Swinnen LJet al.
Aggressive treatment for postcardiac transplant lymphoproliferation.Blood
: 3333–3340.PubMedGoogle Scholar
Leblond Vet al.
Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.J Clin Oncol
: 961–968.PubMedGoogle Scholar
McKelvey EMet al.
Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma.Cancer
: 1484–1493.PubMedCrossRefGoogle Scholar
Nalesnik MA. Posttransplantation lymphoproliferative disorders (PTLD) current perspectives.Sem Thorac Cardiovasc Surg
: 139–148.Google Scholar
Savoie Aet al.
Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease.Blood
: 2715–2722.PubMedGoogle Scholar
Hanson MNet al.
Posttransplant T-cell lymphoproliferative disorders—an aggressive, late complication of solid-organ transplantation.Blood
: 3626–3633.PubMedGoogle Scholar
Alfrey EJet al.
A recent decrease in the time to development of monomorphous and polymorphous posttransplant lymphoproliferative disorder.Transplantation
: 250–253.PubMedCrossRefGoogle Scholar
Oda Det al.
Oral presentation of posttransplantation lymphoproliferative disorder.Transplantation
: 435–440.PubMedCrossRefGoogle Scholar
Pirsch Jet al.
Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation.Am J Med
: 241–244.PubMedCrossRefGoogle Scholar
Antoine Cet al.
Successful treatment of posttransplant lymphoproliferative disorder with renal graft preservation bymonoclonal antibody therapy.Transplant Proc
: 2825–2826.PubMedGoogle Scholar
Lazarovits AIet al.
Anti-B cell antibodies for the treatment of monoclonal Epstein-Barr virus-induced lymphoproliferative syndrome after multivisceral transplantation.Clin Invest Med
: 621–625.PubMedGoogle Scholar
Fischer Aet al.
Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.N Engl J Med
: 1451–1456.PubMedCrossRefGoogle Scholar
O'Brien Set al.
Remission of posttransplant lymphoproliferative disorder after interferon alfa therapy.J Am Soc Nephrol
: 1483–1490.Google Scholar
Nalesnik MAet al.
Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients.Transplant Proc
: 1905–1906.PubMedCrossRefGoogle Scholar
Emanuel Det al.
Treatment of posttransplant lymphoproliferative disease in the central nervous system of a lung transplant recipient using allogeneic leukocytes.Transplantation
: 1691–1694.PubMedCrossRefGoogle Scholar
Garrett TJet al.
Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicinvincristine-prednisone chemotherapy.Cancer
: 2782–2785.PubMedCrossRefGoogle Scholar
Miller Tet al.
Chemotherapy alone compared with chemotherapy plus radiography for localized intermediate and high-grade non-Hodgkin's lymphoma.N Engl J Med
: 21–26.PubMedCrossRefGoogle Scholar
Tondini Cet al.
Combined modality treatment with Primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphoma.J Clin Oncol
: 720–725.PubMedGoogle Scholar